245 related articles for article (PubMed ID: 22448030)
21. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
22. Lower cost strategies for triage of human papillomavirus DNA-positive women.
Qiao YL; Jeronimo J; Zhao FH; Schweizer J; Chen W; Valdez M; Lu P; Zhang X; Kang LN; Bansil P; Paul P; Mahoney C; Berard-Bergery M; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
Int J Cancer; 2014 Jun; 134(12):2891-901. PubMed ID: 24248915
[TBL] [Abstract][Full Text] [Related]
23. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.
Castle PE; Glass AG; Rush BB; Scott DR; Wentzensen N; Gage JC; Buckland J; Rydzak G; Lorincz AT; Wacholder S
J Clin Oncol; 2012 Sep; 30(25):3044-50. PubMed ID: 22851570
[TBL] [Abstract][Full Text] [Related]
24. Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management.
Castle PE; Aslam S; Behrens C
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1595-1599. PubMed ID: 27587789
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials.
Tota JE; Struyf F; Sampson JN; Gonzalez P; Ryser M; Herrero R; Schussler J; Karkada N; Rodriguez AC; Folschweiller N; Porras C; Schiffman M; Schiller JT; Quint W; Kreimer AR; Wheeler CM; Hildesheim A;
J Natl Cancer Inst; 2020 Aug; 112(8):818-828. PubMed ID: 31697384
[TBL] [Abstract][Full Text] [Related]
26. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
[TBL] [Abstract][Full Text] [Related]
27. Genotype-specific methylation of HPV in cervical intraepithelial neoplasia.
Hsu YW; Huang RL; Su PH; Chen YC; Wang HC; Liao CC; Lai HC
J Gynecol Oncol; 2017 Jul; 28(4):e56. PubMed ID: 28541643
[TBL] [Abstract][Full Text] [Related]
28. Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16.
Louvanto K; Franco EL; Ramanakumar AV; Vasiljević N; Scibior-Bentkowska D; Koushik A; Cuzick J; Coutlée F; Lorincz AT;
Int J Cancer; 2015 Mar; 136(6):E638-45. PubMed ID: 25203794
[TBL] [Abstract][Full Text] [Related]
29. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
[TBL] [Abstract][Full Text] [Related]
30. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
[TBL] [Abstract][Full Text] [Related]
31. HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women.
Mirabello L; Yeager M; Cullen M; Boland JF; Chen Z; Wentzensen N; Zhang X; Yu K; Yang Q; Mitchell J; Roberson D; Bass S; Xiao Y; Burdett L; Raine-Bennett T; Lorey T; Castle PE; Burk RD; Schiffman M
J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27130930
[TBL] [Abstract][Full Text] [Related]
32. [Relationship between the methylation of L1 3' and long control region gene of HPV16 DNA and it's pathogenicity].
Hu YJ; Qu PP
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):607-10. PubMed ID: 24199927
[TBL] [Abstract][Full Text] [Related]
33. Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression.
Liu P; Iden M; Fye S; Huang YW; Hopp E; Chu C; Lu Y; Rader JS
Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):642-650. PubMed ID: 28069683
[No Abstract] [Full Text] [Related]
34. Triaging women with human papillomavirus infection and normal cytology or low-grade dyskaryosis: evidence from 10-year follow up of the ARTISTIC trial cohort.
Gilham C; Sargent A; Peto J
BJOG; 2020 Jan; 127(1):58-68. PubMed ID: 31541495
[TBL] [Abstract][Full Text] [Related]
35. HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer.
Mirabello L; Frimer M; Harari A; McAndrew T; Smith B; Chen Z; Wentzensen N; Wacholder S; Castle PE; Raine-Bennett T; Schiffman M; Burk RD
Int J Cancer; 2015 Feb; 136(4):E146-53. PubMed ID: 25081507
[TBL] [Abstract][Full Text] [Related]
36. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
Clarke MA; Luhn P; Gage JC; Bodelon C; Dunn ST; Walker J; Zuna R; Hewitt S; Killian JK; Yan L; Miller A; Schiffman M; Wentzensen N
Int J Cancer; 2017 Aug; 141(4):701-710. PubMed ID: 28500655
[TBL] [Abstract][Full Text] [Related]
37. Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samples.
Fertey J; Hagmann J; Ruscheweyh HJ; Munk C; Kjaer S; Huson D; Haedicke-Jarboui J; Stubenrauch F; Iftner T
Cancer Med; 2020 Feb; 9(3):1058-1068. PubMed ID: 31856411
[TBL] [Abstract][Full Text] [Related]
38. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.
Wheeler CM; Hunt WC; Cuzick J; Langsfeld E; Robertson M; Castle PE;
Int J Cancer; 2014 Aug; 135(3):624-34. PubMed ID: 24226935
[TBL] [Abstract][Full Text] [Related]
39. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
Castle PE; Rodríguez AC; Burk RD; Herrero R; Wacholder S; Alfaro M; Morales J; Guillen D; Sherman ME; Solomon D; Schiffman M;
BMJ; 2009 Jul; 339():b2569. PubMed ID: 19638649
[TBL] [Abstract][Full Text] [Related]
40. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.
Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM
Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]